Freeline Therapeutics (FRLN) has launched the roadshow for its IPO of up to 7,352,941 American Depositary Shares (ADSs).
The price is currently expected to be between $16.00 and $18.00 per ADS, resulting in a total offering size of $117.6M to $132.4M.
Underwriters’ over-allotment is an additional 1,102,941 ADSs.
Previously: Freeline Therapeutics on deck for IPO (July 17)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.